30 mg N/R Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A injection [2 x 3256 Symptomatic Paget disease of bone 30 mg vials] (&) inert substance diluent [2 x 10 mL ampoules], 1 pack 15 mg N/R Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A injection [4 x 3256 Symptomatic Paget disease of bone 15 mg vials] (&) inert substance diluent [4 x 5 mL ampoules] Clodronate 400 mg N/R Maintenance treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy; N/A sodium Multiple myeloma Bone metastases from breast cancer 800 mg N/R Maintenance treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy; N/A Multiple myeloma Bone metastases from breast cancer -Tiludronate 200 mg 3256 Symptomatic Paget disease of bone N/A Disodium -Ibandronic Acid 6 mg/6 mL 3343 Bone metastases from breast cancer N/A injection, 1 x 6 mL vial 50 mg N/R Bone metastases from breast cancer N/A Zoledronic Acid 4 mg/5 mL N/R Multiple myeloma N/A injection, 1 x 5 3342 Bone metastases from breast cancer mL vial 3343 Bone metastases from castration-resistant prostate cancer 4052 Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy 3341 4100 Corticosteroid-induced osteoporosis in a patient currently on (prednisolone or equivalent) corticosteroid ≤-1.5 therapy.
30 mg injection [2 x 30 mg vials] (&) inert substance diluent [2 x 10 mL ampoules], 1 pack N/R 3256 Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy Symptomatic Paget disease of bone N/A 15 mg injection [4 x 15 mg vials] (&) inert substance diluent [4 x 5 mL ampoules] N/R 3256 Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy Symptomatic Paget disease of bone N/A Clodronate sodium 400 mg N/R Maintenance treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy; Multiple myeloma Bone metastases from breast cancer N/A 800 mg N/R Maintenance treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy; Multiple myeloma Bone metastases from breast cancer N/A -Tiludronate Disodium 200 mg 3256 Symptomatic Paget disease of bone N/A -Ibandronic Acid 6 mg/6 mL injection, 1 x 6 mL vial 3343 Bone metastases from breast cancer N/A 50 mg N/R Bone metastases from breast cancer N/A Zoledronic Acid 4 mg/5 mL injection, 1 x 5 mL vial N/R 3342 3343 4052 3341 Multiple myeloma Bone metastases from breast cancer Bone metastases from castration-resistant prostate cancer Treatment of hypercalcaemia of malignancy refractory to anti-neoplastic therapy N/A 4100 Corticosteroid-induced osteoporosis in a patient currently on (prednisolone or equivalent) corticosteroid therapy. ≤-1.5
App1317-FinalDAP-accessible.docx